Febuxostat treatment for gout: what the clinician needs to know.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2009, v. 1, n. 2, p. 67, doi. 10.1177/1759720X09347037
- By:
- Publication type:
- Article
Works matching IS 1759720X AND DT 2009 AND VI 1 AND IP 2
Results: 6
1
2
NICE: its influence in treating osteoporosis in the UK and beyond.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2009, v. 1, n. 2, p. 63, doi. 10.1177/1759720X09354945
- By:
- Publication type:
- Article
3
Paget’s disease of bone: a review of epidemiology, pathophysiology and management.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2009, v. 1, n. 2, p. 107, doi. 10.1177/1759720X09351779
- By:
- Publication type:
- Article
4
Understanding personalized medicine in rheumatoid arthritis: a clinician’s guide to the future.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2009, v. 1, n. 2, p. 97, doi. 10.1177/1759720X09351778
- By:
- Publication type:
- Article
5
Glucocorticoid-induced osteoporosis: treatment update and review.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2009, v. 1, n. 2, p. 71, doi. 10.1177/1759720X09343729
- By:
- Publication type:
- Article
6
Advancing our understanding of osteocyte cell biology.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2009, v. 1, n. 2, p. 87, doi. 10.1177/1759720X09341484
- By:
- Publication type:
- Article